Search
for
Sort by
Research 361–390 of 1000+
- Examining the association of menarche and correlates in a rural polycystic ovary syndrome population: A cross-sectional study
- Cancer risk in polycystic ovary syndrome patients: Common treatments and future perspectives
- Nutritional Assessment of Selected Emerging Adult Women with Poly Cystic Ovarian Syndrome
- Effect of High Levels of Testosterone on Cardiovascular Risk in Polycystic Ovary Syndrome (PCOS)
- Pilosebaceous Unit (PSU)
- Nonalcoholic fatty liver disease and polycystic ovary syndrome
- Evidence-based approach to cutaneous hyperandrogenism in women
- A Clinical Approach to Severe Insulin Resistance
- CLINICAL UPDATES IN HAIR
- Polycystic ovary syndrome: diagnosis and management of related infertility
- Rheumatologic Manifestations of Pregnancy
- Adipose-Derived Stem/Stromal Cells
- Body mass index as a potential confounder in dutasteride and fertility studies
- Cardiometabolic and neuroimaging correlates of cognitive function in polycystic ovary syndrome
- A Review: Proteins Involved in the Major Symptoms of Polycystic Ovarian Syndrome
- Minoxidil
- Alopecia Areata
- Millets as a Novel Solution for PCOS Management: a Review
- The Rotterdam Study: 2018 update on objectives, design and main results
- Relative Prevalence of Different Androgen Excess Disorders in 950 Women Referred because of Clinical Hyperandrogenism
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- Treatment of Obstructive Sleep Apnea Improves Cardiometabolic Function in Young Obese Women with Polycystic Ovary Syndrome
- The importance of adequate serum ferritin levels during oral cyproterone acetate and ethinyl oestradiol treatment of diffuse androgen-dependent alopecia in women
- Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS
- Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism
- Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents
- The diagnosis of polycystic ovary syndrome: the criteria are insufficiently robust for clinical research
- Ghrelin levels are suppressed and show a blunted response to oral glucose in women with polycystic ovary syndrome.
- PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN WOMEN WITH POLYCYSTIC OVARY SYNDROME AND ITS CORRELATION WITH METABOLIC SYNDROME
- Aromatase inhibitor therapy and hair loss among breast cancer survivors